Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
21.38 |
14.78 |
14.03 |
13.85 |
13.81 |
Secured loans
Unsecured loans
Total
30.38 |
19.73 |
25.37 |
23.46 |
21.43 |
Gross block
41.22 |
35.08 |
17.69 |
33.40 |
28.51 |
Less : revaluation reserve
Less : accumulated depreciation
20.99 |
17.50 |
- |
16.02 |
12.90 |
Net block
20.23 |
17.58 |
17.69 |
17.38 |
15.60 |
Capital work-in-progress
Investments
Current assets, loans & advances
53.07 |
15.67 |
15.22 |
14.45 |
11.07 |
Less : current liabilities & provisions
44.59 |
15.39 |
9.39 |
10.08 |
6.96 |
Total net current assets
Miscellaneous expenses not written
Total
30.38 |
19.73 |
25.37 |
23.46 |
21.43 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
109.60 |
15.66 |
15.66 |
15.66 |
15.66 |